| 201195-1G |
|
1422176-84-8 |
N-[(R)-(Fluoromethyl)oxidophenyl-λ4-sulfanylidene]-4-methyl-benzenesulfonamide
≥95%,-
|
0 |
C14H14FNO3S2 |
|
|
|
| 201194-1G |
|
1052174-67-0 |
1-[Difluoro(phenylsulfonyl)methyl]-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole
≥95%,-
|
1G |
C16H15F2IO3S |
|
|
|
| 201193-1G |
|
910650-82-7 |
1,1'-[(Fluoromethylene)bis(sulfonyl)]bis-benzene
≥95%,-
|
1G |
C13H11FO4S2 |
|
|
|
| 201192-1G |
|
20808-12-2 |
[(Fluoromethyl)sulfonyl]-benzene
≥95%,-
|
1G |
C7H7FO2S |
|
|
|
| 201191-1G |
|
1236300-44-9 |
1-(1,1-Dimethylethyl)-5-[(fluoromethyl)sulfonyl]-1H-tetrazole
≥95%,-
|
1G |
C6H11FN4O2S |
|
|
|
| 201190-1G |
|
1689584-09-5 |
2-[(Fluorophenylmethyl)sulfonyl]-pyridine
≥95%,-
|
1G |
C12H10FNO2S |
|
|
|
| 201189-1G |
|
1415115-02-4 |
2-[(Fluoroiodomethyl)sulfonyl]-pyridine
≥95%,-
|
1G |
C6H5FINO2S |
|
|
|
| 201188-1G |
|
1365765-53-2 |
2-[(Fluoromethyl)sulfonyl]-pyridine
≥95%,-
|
1G |
C6H6FNO2S |
|
|
|
| 201180-1G |
|
1643366-13-5 |
1,3-Bis[2,6-bis(1-methylethyl)phenyl]-2-imidazolidinylidene](difluoromethyl)-silver
≥95%,-
|
1G |
C28H39AgF2N2 |
|
|
|
| 201179-1G |
|
2271159-65-8 |
[2-Methoxy-1-(methoxycarbonyl)-2-oxoethyl-(4-nitrophenyl)](trifluoromethyl)-Selenium Inner Salt
≥95%,-
|
1G |
C12H10F3NO6Se |
|
|
|
| 201178-1G |
|
1777707-27-3 |
[2-Methoxy-1-(methoxycarbonyl)-2-oxoethyl]phenyl(trifluoromethyl)-sulfonium Inner Salt
≥95%,-
|
1G |
C12H11F3O4S |
|
|
|
| 201177-1G |
|
1949788-49-1 |
(Difluoromethyl)[2-methoxy-1-(methoxycarbonyl)-2-oxoethyl](4-nitrophenyl)-sulfonium Inner Salt
≥95%,-
|
1G |
C12H11F2NO6S |
|
|
|
| 201176-1G |
|
2105970-10-1 |
2-[(Fluoromethyl)(4-nitrophenyl)-λ4-sulfanylidene]-1,3-dimethyl Ester Propanedioic Acid
≥95%,-
|
1G |
C12H12FNO6S |
|
|
|
| 201175-1G |
|
2105970-08-7 |
2-[(Fluoromethyl)phenyl-λ4-sulfanylidene]-1,3-dimethyl Ester Propanedioic Acid
≥95%,-
|
1G |
C12H13FO4S |
|
|
|
| 201117-1G |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C49H63O4P |
|
|
|
| 201117-100MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C49H63O4P |
|
|
|
| 201117-25MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C49H63O4P |
|
|
|
| 201116-1G |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C49H63O4P |
|
|
|
| 201116-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C49H63O4P |
|
|
|
| 201116-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C49H63O4P |
|
|
|
